跳至主要内容
临床试验/NCT01463969
NCT01463969已完成不适用

High Plasma Level of Long Pentraxin 3 is Associated With Insulin Resistance in Women With Polycystic Ovary Syndrome

Gulhane School of Medicine3 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2010年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
3
主要终点
Level of of pentraxin3 in cases with Polycystic Ovarian Syndrome

研究概览

简要总结

In the present study, serum pentraxin 3 level and its relationship with insulin resistance were determined in patients with Polycystic Ovary Syndrome (PCOS. It was found that PTX3 level is increased in patients with PCOS and it is positively correlated with HOMA-IR.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Absence of significant abnormalities on physical examination except hirsutism
  • No lipid lowering, hypoglycemic, antihypertensive or hormone replacement therapy
  • Normal thyroid function and prolactin level
  • Absence of history or evidence of metabolic, cardiovascular, respiratory or hepatic disease

排除标准

  • Possible ovarian tumors,
  • Congenital adrenal hyperplasia or
  • BMI greater than 35 kg/m2

结局指标

主要结局

Level of of pentraxin3 in cases with Polycystic Ovarian Syndrome

时间窗: 1 year

Mean PTX3 was significantly higher in patients with PCOS. This means that there is increased level of inflamation in patients with PCOS.

次要结局

  • Relationship of PTX3 with insuline resistance in patients with PCOS.(1 year)

研究者

发起方
Gulhane School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aydogan Aydogdu

MD

Gulhane School of Medicine

研究点 (3)

Loading locations...

相似试验